Epistem opens US laboratory in Baltimore
Currently offers histology and immunohistochemistry (IHC) services
Epistem, a biotechnology and personalised medicine company based in Manchester, UK, has opened a US laboratory in Baltimore, Maryland to support the expansion of its contract research division within the US.
The Baltimore laboratory is currently offering histology and immunohistochemistry (IHC) services, expanding on the success of the GcLP and GLP compliant UK laboratory. The technical team has already developed IHC protocols for a panel of more than 150 antibodies which are available worldwide.
Catherine Booth, Co-Founder of Epistem and Director of the Contract Services Business, said: 'Epistem's specialist contract research services provide valuable support to drug discovery and development pipelines. We already have strong relationships with both companies, academic and government groups on the East Coast along with a US Business team based in Boston and Baltimore. We are excited to now be providing services locally to support this growing US business.'
